$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Each year, millions of children in the USA receive general anesthesia, many of them under 4 years of age1. Anesthetic-induced developmental neurotoxicity (AIDN) has become a focus of pediatric anesthesia research as it has become imperative to gain an understanding the effects of anesthesia on immature brains. Previous research has shown that commonly used anesthetics, such as isoflurane, can cause increased neuronal apoptosis in the brains of young animals. Studies in children have yielded equivocal results2. Understanding the pathogenesis of AIDN, identifying potential therapeutic targets for its prevention or amelioration, and describing the safest anesthetic regimens available have become urgent goals of the pediatric anesthesia community. The primary aim of this study was to develop an optimal animal model and method for quantifying the effects of anesthetics on the developing brain, and to stimulate carefully designed investigation into the safety of currently widely used anesthetics.
In a recent systematic review of the current body of preclinical literature on AIDN, the authors noted significant methodological heterogeneity in over 900 studies3. Many considered this to be a call for a clinically relevant, well-designed preclinical model, which does not yet exist despite several years of research on this subject. Most rodent models, out of necessity, use an approach that does not allow rigorous physiologic monitoring, blood sampling, or mechanical ventilation. Since the brain is exquisitely sensitive to physiologic derangements, it is difficult to rely upon the results from such models. A primary goal for the development of this model was to design it in such a way that all physiologic variables such as blood gas parameters, body temperature, respiratory parameters etc. are monitored and corrected when necessary.
Additionally, because the neurotoxicity of anesthesia likely depends on the developmental progress of the brain at the time of exposure, an animal model should be chosen that can best mimic the development and structure of the neonatal human brain, to maximize the translational relevance of the results4. The translational piglet model provides the level of clinical relevance sought after in these reviews and editorials, as it is designed to address this need for pertinent preclinical data that can inform future clinical studies.
Isoflurane, a GABA type A (GABAA) receptor agonist and weak NMDA receptor antagonist, is the is a commonly used inhaled anesthetic in clinical practice worldwide. Anesthetics like isoflurane have been considered safe so long as they do not induce hypotension or hypoxia; yet, more subtle effects may be occurring. When the brain is exposed to general anesthesia, the balance of GABA agonism and NMDA antagonism is disrupted, resulting in alterations in cellular architecture, connectivity, and function. In addition, while GABA is generally an inhibitory neurotransmitter, it is known to be excitatory in immature brains5. Precisely when GABA's transition from excitatory to inhibitory occurs is not well understood, and is likely species-dependent.
When an imbalance between excitatory and inhibitory input in the brain occurs during the so-called "brain growth spurt", the resulting excitotoxic dysregulation of critical molecular pathways may lead to abnormal neurodevelopment, such as apoptotic neurodegeneration. In addition to increased apoptosis, oxidative stress and inflammation may also be induced, while neuronal cell proliferation, neuronal migration, and axonal arborization become suppressed or dysregulated6. The net result is neurocognitive disturbances that may persist into adulthood2.
To directly measure the neurotoxic effects of isoflurane on young mammals, neonatal piglets are used. Piglets share more CNS similarities with humans than any other mammal, and as such, their neurodevelopmental and neuroanatomical similarities make them an ideal animal for a clinically-relevant mammalian model of AIDN. Both humans and piglets possess gyrencephalic brains, sharing similarities in the character and distribution of brain gyri, gray matter, and white matter. The piglet hippocampus, basal ganglia, and brainstem are also topographically similar to that of humans7. Developmentally, piglets are one of the few non-human mammals that undergo perinatal brain growth and myelination8. In utero, both human and piglet brains undergo significant growth during late trimester gestation. In correlation, at birth, human and piglet brains are 27% and 25% of adult brains, respectively. Magnetic resonance imaging has revealed that a one week old piglet brain is approximately equivalent to a one month old human brain in terms of neuronal maturation and dendritic arborization9. Additionally, the piglet and human brain share numerous similarities with respect to patterns of neurodevelopment. For example, the expression and mRNA sequence of reelin10, the topographical distribution of 5-HT neurons11, and neural tube closure12 are all parallel to that which is seen in humans. Furthermore, there is extensive homology between the genomes of piglets and humans13.
The relevance of an animal model must be understood in the context of human pathology, particularly in relation to the brain maturity and pathobiology of the human infant. Most of the existing anesthesia toxicity studies use a rodent model, with a few utilizing non-human primate models. However, rodents and primates may not be the ideal animals for investigating AIDN.
Though widely used, rodent brains are very different from that of humans throughout development. Most notably, rodents possess lissencephalic (or smooth) brains. The rodent brain lacks the gyri and sulci that are characteristic of more neurologically complex organisms. The rodent brain also undergoes a postnatal brain growth spurt14, dissimilar to humans and piglets. It has been observed that there are variations in the vulnerability of different brain regions to inhaled anesthetic15. Therefore, it should be important that the animal model for studying AIDN possess a brain that is neurodevelopmentally and neuroanatomically similar to that of a human, so as to best model the anesthesia-induced brain alterations that is likely to be seen in pediatric patients. As described previously, piglets possess a brain that is much better suited for this role. Furthermore, the common forms of rodent neurocognitive testing, such as spatial learning and memory evaluated in the Morris water maze, are not directly relevant or comparable to the neurocognitive assessments in young children16. One of the advantages of using piglets for developmental neuroscience is that they are extremely amenable to neurocognitive testing, even at an early age. Numerous neurocognitive tests that are considered useful for other mammalian species have been successfully used and validated in pigs. While still an evolving field, neurocognitive assessment in piglets includes more complex tests that better mimics human deficits, such as an inclined beam motor test17,18 and mirror spatial awareness test19. Motor testing with the inclined beam, as part of traumatic brain injury study in piglets, shows high reliability in assessment of motor function. The mirror test demonstrates memory of the surrounding environment plus recognition and utilization of a reflected image to seek out food reward.
On the other hand, non-human primates may be a more appropriate model for pediatric anesthesia studies, but there are a number of prohibitive factors, including cost and difficulty of use. Additionally, they are extremely sensitive to early rearing conditions, particularly stress and maternal separation20. Factors important to the study of AIDN, such as allosteric modulators, receptor-ligand affinities, post-translational modifications, receptor subunit compositions, and alternative splicing variants, are unknown in the case of primates. This is because genes relevant to such concepts have not been cloned. In contrast, they have been cloned in pigs. As such, only limited work has been done in non-human primates21,22.
The piglet model capitalizes on the advantages of the rodent and non-human primate models: it is cost effective, easy to use relative to non-human primate studies, and is neuroanatomically and neurophysiologically similar to the pediatric human brain. The use of piglet in neuroscience research has grown in the recent years, including a number of studies that have examined pediatric neuroinflammatory conditions. Effects of respiratory viral infection on hippocampus and spatial learning23, reducing brain cell death following stroke24, neurogenesis following traumatic brain injury25, and enzyme activity during seizures26 are some of the studies that have used neonatal piglets. This substantial and growing body of literature lends strength to the suitability and sustainability of the clinically relevant and highly reproducible piglet model for the study of anesthesia-induced neurotoxicity.